- Market Capitalization, $K 100,666
- Shares Outstanding, K 75,124
- Annual Sales, $ 72,050 K
- Annual Income, $ -16,540 K
- 60-Month Beta 1.72
- Price/Sales 1.45
- Price/Cash Flow N/A
- Price/Book 3.85
|Period||Period Low||Period High||Performance|
| || |
-0.2600 (-16.25%)since 11/08/23
| || |
-0.2000 (-12.99%)since 09/08/23
| || |
-0.2200 (-14.10%)since 12/08/22
Air Products and Chemicals’ (APD) fourth-quarter earnings beat analysts’ estimates, but the specialty chemicals producer lagged on revenues. However, given a remarkable track record of 41 consecutive...
With its robust demand and contributions to various sectors, the chemical industry is poised for sustained growth. Hence, fundamentally sound chemical stocks Oil-Dri (ODC), Akzo Nobel (AKZOY), Kuraray...
Amid sustained demand from diverse end-use sectors and the swift adoption of emerging technologies, the chemical industry stands on the brink of substantial long-term expansion. Within this context, let’s...
The chemical sector playing an indispensable role in a variety of industries, technological developments, and the high demand for chemical innovations and solutions are expected to drive its growth. Therefore,...
With the diverse applications of chemicals across various industries, the future of the chemical industry appears promising. Therefore, loading up the shares of three fundamentally sound chemical companies...
With the sustained demand for chemicals from end-use sectors and the adoption of emerging technologies, the chemical industry is well-placed to experience robust long-term growth. Given the industry tailwinds,...
Given the significance of the chemical sector’s role in various industries, the strong demand for chemical innovations and solutions is expected to drive its growth. Therefore, investors could benefit...
The chemical industry is well-poised for robust growth in the long term, thanks to the strong demand for specialty chemicals and the integration of digital technologies to drive value chain improvements...
ChromaDex (CDXC) delivered earnings and revenue surprises of 40% and 16.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Arcutis Biotherapeutics, Inc. (ARQT) delivered earnings and revenue surprises of -0.77% and 20.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...
|3rd Resistance Point||1.4693|
|2nd Resistance Point||1.4395|
|1st Resistance Point||1.3898|
|1st Support Level||1.3103|
|2nd Support Level||1.2805|
|3rd Support Level||1.2308|